The first diabetic patient in a phase II trial of Transition Therapeutics' gastrin analogue, TT 223, has been dosed.

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1657, 2008-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase III trial of Reopro [abciximab] for the treatment of patients with acute ischaemic stroke (AbESTT-II) has been temporarily suspended

Reactions Weekly, Vol. 1, Iss. 1073, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The vitamin D3 analogue falecalcitriol has been launched in Japan

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium

By Nimeiri Halla Singh Deepti Kasza Kristen Taber David Ansari Rafat Vokes Everett Kindler Hedy

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 854-858

Springer Publishing Company

Access to resources Recommend Favorite

A report of a multicentre phase II trial has revealed encouraging results for the use of A 002 in patients with stable coronary heart disease

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Millennium Pharmaceuticals has stopped further accrual into its phase II clinical trial investigating the efficacy of bortezomib

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite